NPI: 1336467703 · MEMPHIS, TN 38116 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 05/11/2010
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 05/11/2010 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 12,826 | $124K |
| 2019 | 11,024 | $150K |
| 2020 | 10,829 | $121K |
| 2021 | 6,456 | $77K |
| 2022 | 1,509 | $56K |
| 2023 | 873 | $29K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 15,287 | 1,236 | $302K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 12,656 | 885 | $180K |
| 83970 | 951 | 637 | $30K | |
| A4657 | Syringe, with or without needle, each | 2,488 | 916 | $10K |
| 82108 | 393 | 341 | $8K | |
| 82728 | 651 | 569 | $7K | |
| J1756 | Injection, iron sucrose, 1 mg | 1,778 | 549 | $7K |
| J1270 | Injection, doxercalciferol, 1 mcg | 6,938 | 677 | $4K |
| 83540 | 672 | 582 | $3K | |
| 83550 | 455 | 393 | $3K | |
| 85041 | 573 | 508 | $1K | |
| 85048 | 570 | 505 | $1K | |
| 90674 | 17 | 14 | $232.89 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 57 | 41 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 31 | 28 | $0.00 |